3-186048773-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBS1BS2
The NM_004454.3(ETV5):c.1399C>T(p.Leu467=) variant causes a synonymous change. The variant allele was found at a frequency of 0.00146 in 1,614,142 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0080 ( 14 hom., cov: 32)
Exomes 𝑓: 0.00079 ( 18 hom. )
Consequence
ETV5
NM_004454.3 synonymous
NM_004454.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.88
Genes affected
ETV5 (HGNC:3494): (ETS variant transcription factor 5) Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in cellular response to oxidative stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 3-186048773-G-A is Benign according to our data. Variant chr3-186048773-G-A is described in ClinVar as [Benign]. Clinvar id is 785073.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00797 (1214/152272) while in subpopulation AFR AF= 0.028 (1163/41544). AF 95% confidence interval is 0.0267. There are 14 homozygotes in gnomad4. There are 566 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1214 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ETV5 | NM_004454.3 | c.1399C>T | p.Leu467= | synonymous_variant | 13/13 | ENST00000306376.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ETV5 | ENST00000306376.10 | c.1399C>T | p.Leu467= | synonymous_variant | 13/13 | 1 | NM_004454.3 | P1 | |
ETV5 | ENST00000434744.5 | c.1399C>T | p.Leu467= | synonymous_variant | 13/13 | 1 | P1 | ||
ETV5 | ENST00000480706.1 | n.573C>T | non_coding_transcript_exon_variant | 5/5 | 3 | ||||
ETV5 | ENST00000433149.1 | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00797 AC: 1213AN: 152154Hom.: 14 Cov.: 32
GnomAD3 genomes
AF:
AC:
1213
AN:
152154
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00200 AC: 502AN: 250638Hom.: 5 AF XY: 0.00132 AC XY: 179AN XY: 135486
GnomAD3 exomes
AF:
AC:
502
AN:
250638
Hom.:
AF XY:
AC XY:
179
AN XY:
135486
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000785 AC: 1148AN: 1461870Hom.: 18 Cov.: 31 AF XY: 0.000648 AC XY: 471AN XY: 727238
GnomAD4 exome
AF:
AC:
1148
AN:
1461870
Hom.:
Cov.:
31
AF XY:
AC XY:
471
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00797 AC: 1214AN: 152272Hom.: 14 Cov.: 32 AF XY: 0.00760 AC XY: 566AN XY: 74450
GnomAD4 genome
AF:
AC:
1214
AN:
152272
Hom.:
Cov.:
32
AF XY:
AC XY:
566
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 19, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at